Literature DB >> 22410649

Hearing outcomes following microvascular decompression for hemifacial spasm.

Aalap Shah1, Tara Nikonow, Parthasarathy Thirumala, Barry Hirsch, Yuefang Chang, Paul Gardner, Jeffrey Balzer, Miguel Habeych, Donald Crammond, Lois Burkhart, Michael Horowitz.   

Abstract

PURPOSE: Facial nerve microvascular decompression (MVD) for hemifacial spasm (HFS) provides relief to most patients. Due to the proximity of the cochlear and facial nerves, hearing loss is a potential MVD complication, however, there is a wide range in the reported incidence of hearing loss (HL) in the literature. In order to better understand the HL incidence in our MVD population, we utilized the combination of speech discrimination scores (SDS) and air and bone pure tone threshold averages (PTA) to identify patients with no hearing change, sensorineural hearing loss, or conductive hearing loss. We also assessed the predictive value of patient-reported hearing deficits on the ultimate audiometric diagnosis of hearing loss.
METHODS: One hundred and fifty one patients underwent facial nerve MVD at the University of Pittsburgh Medical Center between January 2000 and December 2007. Peri-operative audiometric data, including changes in air and bone pure tone thresholds and speech discrimination scores, were analyzed retrospectively. Criteria from the 1995 American Academy of Otolaryngology Committee on Hearing and Equilibrium consensus were used to analyze post-operative hearing loss. Patient-reported hearing disturbances obtained in the immediate post-operative period were compared to seven-day post-operative conductive and sensorineural HL status.
RESULTS: Non-functional, non-serviceable HL (Class D) occurred in 6.6% of patients, while 10.6% developed cumulative non-functional HL (Class C and D). Twenty-nine patients (18.7%) exhibited conductive HL. While patient-reported complaints were predictive of Class C/D HL (<0.0001) with a 56.3% sensitivity and 92.6% specificity, patient-reported complaints were not strongly associated with conductive HL status (p = 0.369) with 17.2% sensitivity and 88.5% specificity.
CONCLUSIONS: Perioperative hearing evaluations, in conjunction with careful scrutiny of patient complaints and air-bone pure tone testing enables the physician to more precisely quote complication rates and rapidly distinguish potentially reversible conductive hearing pathologies from permanent sensorineural disorders.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22410649     DOI: 10.1016/j.clineuro.2012.01.016

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Postoperative complications of microvascular decompression for hemifacial spasm: lessons from experience of 2040 cases.

Authors:  Min Ho Lee; Tae Keun Jee; Jeong Ah Lee; Kwan Park
Journal:  Neurosurg Rev       Date:  2015-09-18       Impact factor: 3.042

2.  Microvascular decompression for hemifacial spasm: focus on late reoperation.

Authors:  Xuhui Wang; Parthasarathy D Thirumala; Aalap Shah; Paul Gardner; Miguel Habeych; Donald Crammond; Jeffrey Balzer; Lois Burkhart; Michael Horowitz
Journal:  Neurosurg Rev       Date:  2013-06-10       Impact factor: 3.042

3.  Brainstem Auditory Evoked Potentials' Diagnostic Accuracy for Hearing Loss: Systematic Review and Meta-Analysis.

Authors:  Parthasarathy D Thirumala; Gregory Carnovale; Yoon Loke; Miguel E Habeych; Donald J Crammond; Jeffrey R Balzer; Raymond F Sekula
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-20

4.  Neurotologic Complications Following Microvascular Decompression: A Retrospective Study.

Authors:  Matthew Bartindale; Ayah Mohamed; Jason Bell; Matthew Kircher; Jacqueline Hill; Douglas Anderson; John Leonetti
Journal:  J Neurol Surg B Skull Base       Date:  2019-02-14

Review 5.  Hearing Loss following Posterior Fossa Microvascular Decompression: A Systematic Review.

Authors:  Matthew Bartindale; Matthew Kircher; William Adams; Neelam Balasubramanian; Jeffrey Liles; Jason Bell; John Leonetti
Journal:  Otolaryngol Head Neck Surg       Date:  2017-09-12       Impact factor: 3.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.